PANTOPAQUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pantopaque, and when can generic versions of Pantopaque launch?
Pantopaque is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PANTOPAQUE is iophendylate. Additional details are available on the iophendylate profile page.
Summary for PANTOPAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PANTOPAQUE at DailyMed |
US Patents and Regulatory Information for PANTOPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | PANTOPAQUE | iophendylate | INJECTABLE;INJECTION | 005319-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |